Omega Healthcare Investors (NYSE:OHI – Get Free Report)‘s stock had its “overweight” rating reissued by analysts at Wells Fargo & Company in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $43.00 target price on the real estate investment trust’s stock, up from their prior target price of $40.00. Wells Fargo & Company‘s target price suggests a potential upside of 5.57% from the company’s current price.
A number of other brokerages have also recently weighed in on OHI. Truist Financial upped their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a report on Wednesday, September 4th. Mizuho downgraded Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and raised their price target for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Finally, Scotiabank increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. Eight research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $35.78.
Get Our Latest Stock Report on Omega Healthcare Investors
Omega Healthcare Investors Stock Up 0.1 %
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.20). The firm had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. Omega Healthcare Investors’s revenue for the quarter was up 17.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.74 earnings per share. On average, research analysts forecast that Omega Healthcare Investors will post 2.69 EPS for the current year.
Institutional Trading of Omega Healthcare Investors
A number of hedge funds and other institutional investors have recently modified their holdings of OHI. Hsbc Holdings PLC increased its stake in Omega Healthcare Investors by 107.2% in the 4th quarter. Hsbc Holdings PLC now owns 249,374 shares of the real estate investment trust’s stock worth $7,669,000 after buying an additional 129,009 shares in the last quarter. Stifel Financial Corp grew its position in shares of Omega Healthcare Investors by 1.0% during the fourth quarter. Stifel Financial Corp now owns 344,421 shares of the real estate investment trust’s stock worth $10,560,000 after purchasing an additional 3,514 shares in the last quarter. Treasurer of the State of North Carolina raised its stake in Omega Healthcare Investors by 5.4% during the 4th quarter. Treasurer of the State of North Carolina now owns 111,844 shares of the real estate investment trust’s stock valued at $3,429,000 after purchasing an additional 5,689 shares during the period. Cibc World Markets Corp purchased a new position in Omega Healthcare Investors in the 4th quarter worth approximately $2,489,000. Finally, Waterloo Capital L.P. purchased a new position in Omega Healthcare Investors in the 4th quarter worth approximately $2,380,000. 65.25% of the stock is owned by hedge funds and other institutional investors.
Omega Healthcare Investors Company Profile
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Featured Stories
- Five stocks we like better than Omega Healthcare Investors
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
- What is a SEC Filing?
- Top 3 Stocks Set to Benefit from China’s Interest Rate Cuts
- How to Effectively Use the MarketBeat Ratings Screener
- Broadcom Defies Volatility: Why Wall Street Expects More Gains
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.